Tag: IP
Patents in Motion: The Troubling Implications of the N-Data Settlement
This article is part of a Chronicle. See more from this Chronicle
Anne Layne-Farrar, Mar 26, 2009
A little over a year ago, in January 2008,...
The Intersection of Antitrust, Patents, and FDA Law: The TriCor Litigation
This article is part of a Chronicle. See more from this Chronicle
Richard Epstein, Mar 26, 2009
The purpose of this brief essay is to address...
DG Competition’s Preliminary Report on the Pharma Sector Inquiry: A Need...
This article is part of a Chronicle. See more from this Chronicle
David Hull, Feb 25, 2009
Much of the discussion at the time of the...
The Interplay of Patenting Strategies and Competition Law in the Pharmaceutical...
This article is part of a Chronicle. See more from this Chronicle
Kristina Nordlander, Stephen Spinks, Feb 24, 2009
In the presentation of its Preliminary Report...
The Intersection of Antitrust Law and Intellectual Property Rights Under the...
This article is part of a Chronicle. See more from this Chronicle
Christopher R. Leslie, Jan 20, 2009
Political predictions are fraught with peril. Correctly foretelling...
The 2008 EC Sector Inquiry Regarding Pharmaceuticals: What Does It Mean...
This article is part of a Chronicle. See more from this Chronicle
Kent Bernard, Nov 12, 2008
A sector inquiry is never pleasant for the sector...
Schumpeterian Competition and Antitrust
Herbert Hovenkamp, Nov 01, 2008
Joseph Schumpeter´s vision of competition saw it as a destructive process in which effort, assets, and fortunes were continuously destroyed...
Microsoft (EC) and Duty to Deal: Exceptionality and the Transatlantic Divide
Eleanor Fox, Apr 24, 2008
This article examines Microsoft´s offense in withholding full information to its workgroup server operating systems rivals so that they could...
